Evidence map›Paper›PMID 18501427›Full record

ArticleMolecular immunology2008

Requirement of Galphai in thymic homing and early T cell development.

YongZhu Jin, Mei X Wu

Abstract read
In one paragraph

Article in Molecular immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Loss of GαScientific reports · 2017
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

YongZhu JinWellman Center of Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA.
Mei X Wu

Funding

Autoimmunity in IEX-1- transgenic miceR01AI050822 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WU, MEI X · 2003 to 2006
$1.3M
IEX-1 in bridge of innate to adaptive immune responses to memory T cellsK02AI070785 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WU, MEI X · 2006 to 2010
$531k
NIAID NIH HHS AI050822NIAID NIH HHS AI070785NIAID NIH HHS K02 AI070785NIAID NIH HHS R01 AI050822
6 · The paper itself

Abstract

Demonstration of thymic homing dependent on Galphai proteins is one of the keys to determine whether thymic entrance of blood-borne progenitors is a highly selective process. The present study provides compelling evidence of an indispensable role for Galphai proteins in this process. Absence of either Galphai2 or Galphai3 significantly abrogated thymic homing, with an effect of Galphai3 being greater than that of Galphai2. Pertussis toxin treatment that blocks both Galphai2 and Galphai3 almost completely blocked thymic seeding in the thymus. Null mutation of Galphai3 also hindered bone marrow cell development and thus reduced production of pre-thymic progenitors. In contrast, Galphai2 exhibited a more prominent role than Galphai3 in guidance of CD4-CD8--double negative (DN) 1 cell migration and early thymic differentiation. The Galphai-deficiency-induced defects might be compensated for in part via augmented function of thymic stromal cells so that a nearly normal output of mature T cells could be maintained in these Galphai-deficient mice. These studies underscore the importance of Galphai in regulating thymic homing and pre-thymic and early thymocyte differentiation.

Indexed as

AnimalsAnimals, NewbornCell CountCell DifferentiationChemotaxisGTP-Binding Protein alpha Subunit, Gi2GTP-Binding Protein alpha Subunits, Gi-GoMiceMice, Inbred C57BLStem CellsStromal CellsThymus GlandT-LymphocytesT-Lymphocyte SubsetsGnai2 protein, mouseGnai3 protein, mouseGTP-Binding Protein alpha Subunit, Gi2GTP-Binding Protein alpha Subunits, Gi-Go

Identifiers

PMID18501427
PMCPMC2495766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.